Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|January 1, 1995
Analysis of MHC-specific peptide motifs. Applications in immunotherapyD J Loftus, R T Kubo, K Sakaguchi, et al.The Journal of Cell Biology|March 1, 1987
Microinjection of gelsolin into living cellsJ A Cooper, J Bryan, B Schwab, et al.Cancer Research|June 11, 1998
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35)D J Loftus, P Squarcina, M B Nielsen, et al.Cancer Research|February 2, 1999
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapyL Rivoltini, P Squarcina, D J Loftus, et al.The Journal of Experimental Medicine|August 1, 1996
Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)D J Loftus, C Castelli, T M Clay, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapyL Rivoltini, D J Loftus, K Barracchini, et al.Critical Reviews in Immunology|January 7, 1998
Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivityL Rivoltini, D J Loftus, P Squarcina, et al.The Journal of Experimental Medicine|April 1, 1996
Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccinesJ I Mayordomo, D J Loftus, H Sakamoto, et al.Radiatsionnaia Biologiia, Radioecologiia|September 18, 2007
Shared oxidative pathways in response to gravity-dependent loading and gamma-irradiation of bone marrow-derived skeletal cell progenitorsH Kondo, C Limoli, N D Searby, et al.The Prostate|May 6, 1998
Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)M L Salgaller, P A Lodge, J G McLean, et al.Pageof 3